Omalizumab for asthma in adults and children-Reference-Cited by-同舟云学术

Omalizumab for asthma in adults and children

Published:2014-01-13 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Normansell Rebecca¹,Walker Samantha²³,Milan Stephen J¹,Walters E. Haydn⁴,Nair Parameswaran⁵⁶

Affiliation:

1. St George's, University of London; Population Health Sciences and Education; London UK

2. Asthma UK; London UK

3. University of Edinburgh Medical School; Centre for Population Health Sciences; Edinburgh UK

4. School of Medicine, University of Tasmania; NHMRC CRE for Chronic Respiratory Disease; Hobart Tasmania Australia

5. McMaster University; Firestone Institute for Respiratory Health; Hamilton Ontario Canada

6. St Joseph's Healthcare; Hamilton Ontario Canada

Publisher

Wiley

Subject

Pharmacology (medical)

Reference321 articles.

1. A 26-week, randomized, double-blind, placebo-controlled, multicenter study to evaluate the effect of omalizumab on asthma control in patients with persistent allergic asthma;Bardelas;Journal of Asthma,2012

2. A 26-week, randomized, double-blind, placebo-controlled, multicenter study to evaluate the effect of omalizumab on markers of asthma impairment in patients with persistent allergic asthma [Abstract];Figliomeni;Journal of Allergy and Clinical Immunology,2011

3. NCT00870584 A 26-Week Randomized, Double-blind, Placebo-Controlled, Multi-Center Study to Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma www.clinicaltrials.gov/show/NCT00870584

4. Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response;Boulet;American Journal of Respiratory and Critical Care Medicine,1997

5. Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthma;Bousquet;Chest,2004

Cited by 523 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment;The Lancet;2024-07

2. Real‐world biologics response and super‐response in the International Severe Asthma Registry cohort;Allergy;2024-06-22

3. Clinical remission after biologic therapy discontinuation in pediatric patients with severe asthma: a case series from a tertiary center;Jornal Brasileiro de Pneumologia;2024-06-17

4. The role of anti-IgE therapy in achieving remission of bronchial asthma;Meditsinskiy sovet = Medical Council;2024-06-05

5. Precision medicine for severe asthma – Biological targeted therapy;International Immunopharmacology;2024-06